Drug Profile
Botulinum toxin A liquid - Eirion Therapeutics
Alternative Names: AI-09Latest Information Update: 07 Oct 2022
Price :
$50
*
At a glance
- Originator Anterios
- Developer AbbVie; Eirion Therapeutics
- Class Analgesics; Anti-inflammatories; Antiarrhythmics; Antidepressants; Antimigraines; Antipruritics; Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Eye disorder therapies; Foot disorder therapies; Muscle relaxants; Recombinant proteins; Skin disorder therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Glabellar lines
- Discontinued Acne; Facial wrinkles; Hyperhidrosis